Technology
Health
Biotechnology
NuCana
$9.789876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$9.78
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.20 (2.09%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours
Why Robinhood?
You can buy or sell NuCana and other stocks, options, ETFs, and crypto commission-free!
About NCNA
NuCana Plc engages in the development of technology platform for the treatment of patients with cancer. Its Protide technology is consists of acelarin, NUC-3373, and NUC-7738. Read More The company was founded by Hugh S. Griffith and Christopher B. Wood on January 28, 1997 and is headquartered in Edinburgh, the United Kingdom.
Employees
24
Headquarters
Edinburgh, Midlothian
Founded
1997
Market Cap
304.03M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
52.98K
High Today
$9.74
Low Today
$9.50
Open Price
$9.59
Volume
5.28K
52 Week High
$30.10
52 Week Low
$9.03
Collections
Technology
Health
Biotechnology
Cancer Prevention
2017 IPO
UK
Europe
NCNA News
Price Paid on Robinhood
29% Lower
Right Now
52 Week Low
$9.03
Average Price Paid
$13.71
52 Week High
$30.10
NCNA Earnings
-$21.52
-$14.36
-$7.21
-$0.05
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
—
Actual
Expected Aug 27, After Hours